CEREBROLYSIN
- Low stock - 6 items left
- Backordered, shipping soon
Cerebrolysin
Neurotrophic & Neuroprotective Peptide Mixture
Product Overview
Cerebrolysin is a multi-modal peptide preparation derived from purified porcine brain proteins. It consists of a unique mixture of low-molecular-weight peptides and amino acids that mimic the action of endogenous neurotrophic factors. In a laboratory setting, it is utilized to study neurorecovery, synaptic plasticity, and the protection of neurons against pathological metabolic conditions.
Key Research Applications
-
Neuroprotection: Investigated for its ability to shield neurons from damage and promote survival in models of acute brain injury.
-
Cognitive Research: Extensively studied in dementia models, including Alzheimer’s and vascular dementia, to evaluate improvements in cognitive and global function.
-
Post-Stroke Recovery: Used in preclinical and clinical models to explore the restoration of motor function and neurological repair following ischemic events.
-
Traumatic Brain Injury (TBI): Frequently applied in research to assess neurological outcomes and the brain's innate ability for self-repair after trauma.
-
Synaptic Plasticity: Analyzed for its properties similar to natural brain growth factors, potentially supporting the formation of new neural connections.
Technical Characteristics
-
Source: Enzymatically-treated porcine brain-derived peptides.
-
Composition: Contains fragments of BDNF, GDNF, NGF, and CNTF.
-
Mechanism: Acts via a multi-modal approach to stimulate neurorecovery and metabolic support.
Research Notice: Cerebrolysin is intended for laboratory and scientific research use only. It is not approved by the FDA for human use or medical treatment in the United States.
